4//SEC Filing
Delaet Ingrid 4
Accession 0000914475-25-000002
CIK 0000914475other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:23 PM ET
Size
8.4 KB
Accession
0000914475-25-000002
Insider Transaction Report
Form 4
Delaet Ingrid
Chief Regulatory Officer
Transactions
- Sale
Common Stock
2024-12-31$138.10/sh−272$37,563→ 2,507 total - Exercise/Conversion
Common Stock
2024-12-31$79.02/sh+272$21,493→ 2,779 total - Exercise/Conversion
Non-Qualified Stock Option
2024-12-31−272→ 2,718 totalExercise: $79.02Exp: 2032-01-31→ Common Stock (272 underlying)
Footnotes (2)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2023.
- [F2]The option was granted January 31, 2022 and vests in 48 equal monthly installments beginning February 28, 2022. These options will expire ten years from the date of grant on January 31, 2032.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001965808
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:23 PM ET
- Size
- 8.4 KB